Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYE™-guided persistent atrial fibrillation (AF) ablation procedures conducted as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback